As reported by CISA's ICS-CERT Medical Advisory (ICSMA-26-223-01), Quanovate Tech Inc. — operating under the Mira and Mira Care brands — has been flagged for a cluster of eight critical vulnerabilities affecting both the Mira Hormone Monitor firmware and its companion Android application. The combined CVSS v3 score of 9.8 (Critical) places this advisory among the most severe medical device disclosures of 2026, and the nature of the data at risk makes it especially sensitive.

Security Impact: — operating under the Mira and Mira Care brands — has been flagged for a cluster of eight critical vulnerabilities affecting both the Mira Hormone Monitor firmware and its companion Android application.

Why This Advisory Demands Immediate Attention

Hormone monitoring devices occupy a uniquely sensitive niche in the connected health ecosystem. The Mira device is primarily used by individuals tracking fertility, reproductive cycles, and hormonal health — data that is not only deeply personal but legally sensitive in many jurisdictions following evolving reproductive privacy legislation. A successful attacker exploiting these vulnerabilities could:

Why This Advisory Demands Immediate Attention
Access unauthorized health profiles containing hormonal and reproductive data
Alter recorded health measurements, potentially influencing clinical decisions
Harvest session tokens to achieve persistent account control
Launch denial-of-service conditions against the monitoring platform
Fully compromise user accounts via authentication bypass techniques

This isn't a theoretical risk profile. The vulnerability classes identified — hard-coded credentials, missing authentication for critical functions, and authentication bypass by spoofing — are well-understood attacker primitives that have been reliably weaponized in other IoMT (Internet of Medical Things) campaigns.

Vulnerability Detail Breakdown

Affected Products
Mira Monitor Firmware v1.7.1.47 and Mira Android App v4.5.15.4
Vendor
Quanovate Tech Inc. (Mira / Mira Care)
CVSS v3 Score
9.8 — Critical
CVE Identifiers
CVE-2026-66875, CVE-2026-66098, CVE-2026-67558, CVE-2026-67568, CVE-2026-68067, CVE-2026-66340, CVE-2026-64934, CVE-2026-66832
Vulnerability Classes
Missing Authentication for Critical Function, Authentication Bypass by Spoofing, Use of Hard-coded Credentials, Weak Authentication, Improper Restriction of Excessive Authentication Attempts
Active Exploitation Observed
Not confirmed at time of advisory publication
Patch/Mitigation Available
Refer to CISA advisory and vendor guidance; users should update to patched firmware/app versions when available

The Hard-Coded Credential Problem in IoMT

Hard-coded credentials remain one of the most persistent and damning failures in connected device security. When a manufacturer embeds static authentication values into firmware, every device of that model shares the same skeleton key — and once that key is identified (through reverse engineering, leaked source code, or simply being published in a forum), the entire install base becomes instantly exploitable. For a consumer health device with no enterprise IT team managing it, the exposure window is effectively unlimited.

The presence of multiple authentication-related CVEs here — bypass by spoofing, missing authentication, weak authentication, and excessive authentication attempts — suggests systemic design-level failures rather than isolated coding errors. This pattern is characteristic of devices where security was an afterthought during development rather than a foundational requirement.

Regulatory and Legal Exposure

Healthcare organizations and telehealth providers integrating third-party consumer hormone monitors into care workflows should be acutely aware of the HIPAA and state-level reproductive privacy implications. In states where reproductive health data carries heightened legal protections, a breach of this nature could expose both patients and organizations to significant regulatory liability — independent of any cybersecurity enforcement action.

Shield53 Perspective: The convergence of critical-severity authentication failures with highly sensitive reproductive health data in a consumer IoMT device represents one of the highest-consequence vulnerability profiles we track. The legal, personal, and clinical risks compound each other in ways that demand faster-than-average response from both users and organizations.

Shield53 Recommendations

Immediate Actions

  • Users: Update the Mira Android App to the latest available version immediately and check the Mira/Mira Care vendor channels for firmware update instructions for the physical monitor.
  • Disconnect if unpatched: If no patch is yet available or cannot be applied, consider disconnecting the device from internet-connected services until remediation is confirmed.
  • Revoke and rotate sessions: Log out of all Mira Care accounts, revoke any active sessions, and change account passwords — particularly if credentials were reused on other platforms.
  • Enable MFA: If the Mira platform offers any form of multi-factor authentication, enable it immediately.
  • Healthcare providers: Audit any clinical integrations or data-sharing arrangements involving Mira devices. Suspend automated data ingestion from these devices until vendor remediation is verified.
  • Monitor for anomalies: Users should review account activity logs for unauthorized access or unexplained changes to health data records.

Longer-Term Guidance

  • Organizations evaluating consumer IoMT devices for clinical use should require documented security assessments — including firmware analysis — as part of vendor procurement.
  • Apply the NIST SP 800-213 IoT device cybersecurity framework when assessing similar consumer health devices for enterprise or clinical deployment.
  • Consider network segmentation: any connected health device should operate on an isolated network segment, never sharing infrastructure with clinical or enterprise systems.